 |
 |
 |
 |
 |
 |
 |
|||||
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Duty To Dispense: Overcoming Uncertainty, Doubt and Fear
ACPE Universal Program
Number: 207-000-03-114-H04
Release Date: October 19, 2003
Expiration Date: October 19, 2006
The community pharmacist has a professional responsibility to dispense medications when the medications have been legally prescribed and therapeutically appropriate for the condition being treated. Pharmacists who deny or withhold medication may be held liable for negative consequences of their actions. Often pharmacists can become confused with the professional responsibility to ensure access to medications, especially opioid analgesics; and the legal-regulatory duty to prevent diversion of controlled substances. Underlying the behavior of pharmacists in many instances is the fear of burglary, robbery, or forgery if it is known among criminal elements that opioid analgesics are routinely stocked in their pharmacy. This fear can be so great that a recent study of pharmacies in select neighborhoods reported that 75% of pharmacies did not have sufficient supplies of opioids to treat severe pain. To respond to the need to create a safer environment for pharmacists, a national clearinghouse has recently been launched to assist in the sharing and dissemination of information to law enforcement personnel, as well as proactively assisting pharmacists in reducing the potential for crime.
Educational
Objectives
Upon completion
of this activity, participants should be better able to:
- Understand the rational and therapeutic options in treating patients with persistent pain.
- Discuss regulatory standards and professional responsibilities in the context of access for legitimate patients to opioid analgesics.
- Cite three examples where pharmacists were challenged in court for their decisions regarding patients with prescriptions for schedule II Controlled Substances.
- Describe barriers to the ability of law enforcement personnel to coordinate investigations of pharmacy crime in overlapping jurisdictions.
- Identify three steps pharmacists can take to decrease the opportunity for being victim of pharmacy crime as well as to proactively prevent loss.
Credit
Designation
A score of 70 percent is required to successfully complete
the CE quiz. You will have two opportunities to achieve a passing score.
The Statement of Credit should be printed upon receipt; a duplicate
copy will be available in the participant's online transcript for further
viewing. Individuals must complete this program by October 19, 2006
to receive credit.
NCPA
is approved by the Accreditation Council for Pharmacy Education (ACPE)
as a provider of continuing pharmacy education. This program will provide
2.0 contact hours (.2 CEUs) of continuing pharmaceutical education credit
under the number 207-000-03-114-H04.
Faculty Information
Narinder M. Duggal, BSc Pharm, MD is
the Medical Director of Liberty Bay Internal Medicine in Poulsbo, Washington.
Richard R. Abood, RPh, JD is a Professor of Pharmacy Practice at the University of Pacific in Stockton, California.
J. Aaron Graham is Vice President of Corporate Security for Purdue Pharma, L.P. in Stamford, Connecticut.
Faculty
Disclosure Statements
NCPA has a conflict of interest policy that requires course
faculty to disclose any real or apparent commercial financial affiliations
related to the content of their presentations/materials.
Narinder M. Duggal, BSc Pharm, MD serves as a consultant, is on the speakers' bureau and has received grant/research support from Bristol-Myers Squibb Company, Parke-Davis, Pfizer, Inc., GlaxoSmithKline Pharmaceuticals, Proctor and Gamble, Aventis Pharmaceuticals, Hoechst Marion Roussel, AstraZeneca, Eli Lilly and Company, Novartis Pharmaceuticals, Merck Pharmaceutical Company, Roche Pharmaceuticals, Searle Pharmaceuticals, Purdue Pharma, Takeda America Pharmaceutical, Wyeth-Ayerst and Sankyo Pharma.
Richard R. Abood, RPh, JD regularly serves as a consultant on pharmacy law issues to law firms and pharmacy organizations.
Software Requirements
| PC Windows 98, SE or above Internet Explorer 5.5 or above Netscape 7.02 or above Flash Player Plugin 800 x 600 Minimum Monitor Resolution *Sound Card & Speakers **Adobe Acrobat Reader |
MAC |
| *SLIDES
AND AUDIO ONLY **REQUIRED TO VIEW PRINTABLE VERSION OF CE LESSON | |
This program is supported by an unrestricted educational grant from Purdue
Pharma, L.P.
 |